Similar articles

• Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?

  Dé P, Bechstein WO, Blumhardt G, Lange D, Schattenfroh N, Neuhaus P. Dé P, et al. Transplant Proc. 1993 Aug;25(4):2693-4. Transplant Proc. 1993. PMID: 7689279 Clinical Trial. No abstract available.
• OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.

  Platz KP, Mueller AR, Zytowski M, Bechstein WO, Blumhardt G, Lobeck H, Neuhaus P. Platz KP, et al. Transplant Proc. 1995 Feb;27(1):1111-3. Transplant Proc. 1995. PMID: 7533357 Clinical Trial. No abstract available.
• Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.

  Lange D, Bechstein WO, Blumhardt G, Lemmens P, Schattenfroh N, Neuhaus P. Lange D, et al. Transplant Proc. 1993 Apr;25(2):1870-1. Transplant Proc. 1993. PMID: 8470207 Clinical Trial. No abstract available.
• Clinical and immunological aspects of liver allograft rejection.

  Schlitt HJ. Schlitt HJ. Transplant Proc. 1996 Feb;28(1):514-6. Transplant Proc. 1996. PMID: 8644333 Review. No abstract available.
• Immunosuppressive drugs.

  Bowman H, Lennard TW. Bowman H, et al. Br J Hosp Med. 1992 Nov 4-17;48(9):570-3, 576-9. Br J Hosp Med. 1992. PMID: 1282440 Review.